Graves ophthalmopathy: low-dose glucocorticoid increases peroxisome proliferator-activated receptor-gamma gene expression

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Search for exclusive or semi-exclusive gamma gamma production and observation of exclusive and semi-exclusive e(+)e(-) production in pp collisions at root s=7 TeV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Interferon-gamma production by human neutrophils upon stimulation by IL-12, IL-15 and IL-18 and challenge with Paracoccidioides brasiliensis

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Influence of Fc gamma RIIIb polymorphism on its ability to cooperate with Fc gamma RIIa and CR3 in mediating the oxidative burst of human neutrophils

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Search for excited quarks in the gamma plus jet final state in proton-proton collisions at root s=8 TeV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Search for WW gamma and WZ gamma production and constraints on anomalous quartic gauge couplings in pp collisions at root s=8 TeV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Stability of a product prepared with Fuerte avocados exposed to gamma and UV-C radiation

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Papel reparador e imunomodulador das células-tronco mesenquimais (CTMs) deficientes de receptor para interferon-gamma (IFNy) em modelos renais agudos

A insuficiência renal aguda (IRA) é uma patologia que apresenta alta incidência na população e elevada morbimortalidade. Apesar de todos os avanços terapêuticos já obtidos, essas taxas ainda continuam elevadas. Uma possível alternativa, atualmente sugerida, seria o transplante de células-tronco. O processo regenerativo das células-tronco mesenquimais (CTMs) já foi demonstrado em diversos modelos experimentais e em alguns ensaios clínicos. O mecanismo de ação mais sugerido é a ação parácrina das CTMs na área lesada. Ainda, sabe-se que nesse ambiente, citocinas pró-inflamatórias, como TNF-α e IFNγ, ativam as CTMs para seu papel reparador. O presente estudo busca analisar o papel do IFNγ na ativação das CTMs em modelos renais. As CTMs de animais nocautes para receptor de IFNγ (IFNγR KO) e de animais selvagens (controle/ C57/Bl6) foram isoladas do tecido adiposo. Essas células foram caracterizadas por imunofenotipagem e diferenciação em adipócitos e osteócitos. A lesão renal aguda foi obtida através do clampeamento dos pedículos renais de camundongos machos C57/Bl6, por 45 min. Após 4hs da lesão isquêmica, as CTMs IFNγR KO e CTMs controles foram administradas intraperitonealmente, e 24hs após a cirurgia os animais foram sacrificados. O tratamento com CTMs selvagens apresentou significativa redução dos níveis de uréia e creatinina sérica. No entanto, a redução desses níveis séricos com CTMs IFNγR KO foi menos intensa. Com relação à análise da resposta inflamatória do rim, os dados demonstram que a expressão de RNAm de IL-6 é maior nos animais tratados com CTMs IFNγR KO quando comparada ao tratamento com CTMs selvagens; porém, os dois tratamentos apresentam expressão reduzida em comparação aos animais não tratados. Já a expressão de RNAm de IL-10 é maior em animais tratados com CTMs em comparação aos não tratados... (Resumo completo, clicar acesso eletrônico abaixo)

Phenotypic expression of homozygous hemoglobin S in relation to β-globin haplotypes, glutathione S-transferase polymorphisms and detoxification enzymes

Sickle cell anemia (SCA) shows a pathophysiology that involves multiple changes in sickle cell erythrocytes, vaso-occlusive episodes, hemolysis, activation of inflammatory mediators, endothelial cell dysfunction, and oxidative stress. These events complicate treatment and culminate in the development of manifestations such as anemia, pain crises and multiorgan dysfunction. The aim of this study was to evaluate, in SCA patients, oxidative stress and antioxidant capacity markers, correlating them to treatment with hydroxyurea (HU), β-globin haplotypes and glutathione S-transferase polymorphisms (GSTT1, GSTM1 and GSTP1), in comparison to a control group (CG). The study groups were composed of 48 individuals without hemoglobinopathies (CG), SCA patients treated with HU [AF (+HU), N = 13] and untreated SCA patients [AF (-HU), N = 15], after informed consent. The groups were analyzed using cytological, electrophoretic, chromatographic and molecular methods and information from medical records. The GSTM1 and GSTT1 polymorphisms were determined by multiplex PCR, while the GSTP1 polymorphism by PCR-RFLP. Biochemical parameters were measured using spectrophotometric methods [TBARS, TEAC and catalase (CAT) and GST activities] and a chromatographic method [glutathione (GSH)]. The fetal Hb (Hb F) levels observed in the SCA (+HU) group (10.9%) confirmed the already well-described pharmacological effect of HU, but the SCA (-HU) group also had high Hb F levels (6.1%), which may have been influenced by genetic factors not targeted in this study. We found a higher frequency of the Bantu haplotype (48.2%), followed by the Benin (32.1%) and also Cameroon haplotypes, rare in our population, and 19.7% of atypical haplotypes. The presence of Bantu haplotype was related to higher lipid peroxidation levels in patients, but also, it conferred a differential response to HU treatment, raising Hb F levels in 52.6% (P = 0.03). The protective effect of Hb F was confirmed, because the increase in their levels resulted in a 41.3% decrease in lipid peroxidation levels (r = -0.74, P = 0.0156). The genotypic frequency of the GST polymorphisms observed was similar to that of other studies in the Brazilian population, and its association with biochemical markers revealed a significant difference only for the GSTP1 polymorphism, where patients with genotype V/V showed higher GSH and TEAC levels (P = 0.04 and P = 0.03, respectively) compared to patients with genotype I/I. The TBARS levels were about five to eight times higher in the SCA (+HU) and SCA (-HU) groups, respectively, compared to controls, and HU produced a 35.2% decrease in lipid peroxidation levels in the SCA (+HU) group (P < 0.0001). Moreover, the SCA (+HU) group showed higher TEAC levels when compared to CG (P = 0.002). We did not find any significant difference in GST activity between the groups studied (P = 0.76), but CAT activity was about 17 and 30% lower in SCA (+HU) and SCA (-HU) groups, respectively (P < 0.00001). Plasma GSH levels were ~2 times higher in SCA patients than in the control group (P = 0.0005) and showed a positive correlation with TBARS levels, confirming its antioxidant function. HU treatment contributed to higher CAT activity and TEAC levels and lower lipid peroxidation, and its pharmacological effect showed a “haplotype-dependent” response. These findings may contribute to elucidating the potential of HU in ameliorating oxidative stress in SCA subjects.

Measurement of the Z gamma production cross section in pp collisions at 8 TeV and search for anomalous triple gauge boson couplings

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Excited leptonic states in polarized e(-)gamma and e(+)e(-) collisions

We analyze the capability of the next generation of linear electron-positron colliders to unravel the spin and couplings of excited leptons predicted by composite models. Assuming that these machines will be able to operate both in the e+e- and e-γ modes, we study the effects of the excited electrons of spin 1/2 and 3/2 in the reactions e-γ → e-γ and e+e- → γγ. We show how the use of polarized beams is able not only to increase the reach of these machines, but also to determine the spin and couplings of the excited states.

New Higgs interactions in ZZ gamma and Z gamma gamma production

The effect of new operators that only modify the bosonic couplings of the Higgs boson, without altering the WW gamma or WWZ three-point functions, are examined in the e(+)e(-) --> ZZ gamma and Z gamma gamma processes. We analyse the constraints on these interactions that can be imposed by the LEP II collider at CERN and at the Next Linear Collider. (C) 1998 Elsevier B.V. B.V.

Radiative Omega(-)->Xi(-)gamma decay and physics beyond the standard model

We investigate the impact of new physics beyond the standard model to the s → dγ process, which is responsible for the short-distance contribution to the radiative decay Ω-Ξ-γ. We study three representative extensions of the standard model: namely, a one-family technicolor model, a two-Higgs-doublet model, and a model containing scalar leptoquarks. When constraints arising from the observed b→sγ transition and the upper limit on D0-D̄0 mixing are taken into account, we find no significant contributions of new physics to the s→dy process.

Anomalous couplings in e(+)e(-)->W+W- gamma at CERN LEP 2 and NLC

We present sensitivity limits on the coefficients of a dimension-6 effective Lagrangian that parametrizes the possible effects of new physics beyond the standard model. Our results are based on the study of the process e(+)e(-)-->W+W- y at CERN LEP 2 and NLC energies. In our calculations, we include all the new anomalous interactions, involving vectors and Higgs bosons, and take into account the standard model irreducible background. We analyze the impact of these new interactions on the total cross section. including the effects of the initial electron and final W polarizations. We then focus on the operators that will not be constrained by the e(+)e(-)-->W+W- process, obtaining limits based on the photon energy distribution.